プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Sunday Ojochegbe O.に依頼

Luxembourg

R and D Scientist in Medical device industry | Cancer research | Process Validation | Project Management and Nonprofits

プロフィール概要

Dr. Okutachi is an experienced R and D Scientist in the highly regulated molecular diagnostics | IVD industry. He holds a PhD in Cancer Cell Biology and Drug Discovery as well an MBA degree. His core expertise spans the areas of Product Design and Development, Process Characterization and Validation, Design Transfer, Risk Management and Project Management. In addition to his primary duties at a world leading healthcare company, Sunday also leads a cancer nonprofit organization where he provides leadership and strategy guidance.

専門分野

• ★ Medical Devices
• ★ Healthcare
• ★ Risk Management
• ☆ Biochemistry
• ☆ Molecular Biology
• ☆ PCR
• ☆ Medical Device Regulatory Consulting
• ☆ Cancer Research
• ☆ Business
• ☆ Nonprofit Organization Administration
• ☆ Project Management

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Technical Writing, Copywriting, Newswriting

Research Market Research, User Research, Feasibility Study, Gap Analysis, Gray Literature Search, Systematic Literature Review

Consulting Digital Strategy Consulting

Data & AI Statistical Analysis, Big Data Analytics

Product Development Product Evaluation, Product Validation

職務経験

R&D Scientist-Design Transfer

Siemens Healthineers

7月 2021 - 現在

University of Luxembourg

3月 2018 - 6月 2021

学歴

MBA

Quantic School of Business and Technology

7月 2020 - 7月 2021

PhD in Biology (Cancer Biology)

University of Luxembourg

3月 2018 - 6月 2020

MSc in Translational Oncology (Biomedical Science)

University of Hull

9月 2015 - 9月 2016

BSc. In Biochemistry (Biochemistry)

Kogi State University

1月 2009 - 11月 2012

認定資格

• Prince2 Project Management

  Axelos Global Best Practice

  7月 2020 - 現在

出版物

OTHER

Sunday Okutachi, Ganesh babu Manoharan, Daniel Abankwa(2021). Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells . Cold Spring Harbor Laboratory